Guardant Health, Inc. (GH)
Guardant Health, Inc. (GH)
$94.64 USD
Updated Aug 23 12:00am
Add GH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 132 in Medical - Devices & Equipment
See all “A” rated Strong Buy stocks
GH Stock Chart More Charts
GH Price/Volume Stats
| Current price | $94.64 |
| Prev. close | $98.62 |
| Day low | $94.10 |
| Day high | $99.43 |
| 50-day MA | $92.96 |
| 200-day MA | $66.47 |
| 52-week high | $112.21 |
| 52-week low | $27.04 |
| Volume | 726,200 |
| Avg. volume | 1,010,705 |
| Dividend yield | N/A |
| Market Cap | 8.80B |
Guardant Health, Inc. (GH) Company Bio
Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.
Top Stories View All
Stock of the Week: Verizon Communications (VZ)
Best & Worst Performing Stock Industries for August 23, 2019
Best & Worst Performing Mid Cap Stocks for August 23, 2019
Best & Worst Performing Small Cap Stocks for August 23, 2019
Best & Worst Performing Mega Cap Stocks for August 23, 2019
View All Top Stories
Loading social stream, please wait...